Tali Elfassy

Tali Elfassy

Auto-generated profile, based on publicly available information

Tali Elfassy

Department of Medicine, University of Miami Miller School of Medicine, Miami, FL, United States

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
NKNuzulul Kurniansyah
Nuzulul Kurniansyah
MGMatthew O. Goodman
Matthew O. Goodman
TKTanika N. Kelly
Tanika N. Kelly
TETali Elfassy
Tali Elfassy
KWKerri L. Wiggins
Kerri L. Wiggins
TSTamar Sofer
Tamar Sofer
In a multi-stage analysis of 52,436 individuals aged 17-90 across diverse cohorts and biobanks, we train, test, and evaluate a polygenic risk score (PRS) for hypertension risk and progression. The PRS is trained using genome-wide association studies (GWAS) for systolic, diastolic blood pressure, and hypertension, respectively. For each trait, PRS is selected by optimizing the coefficient of variation (CV) across estimated effect sizes from multiple potential PRS using the same GWAS, after which the 3 trait-specific PRSs are combined via an unweighted sum called “PRSsum”, forming the HTN-PRS. The HTN-PRS is associated with both prevalent and incident hypertension at 4-6 years of follow up. This association is further confirmed in age-stratified analysis. In an independent biobank of 40,201 individuals, the HTN-PRS is confirmed to be predictive of increased risk for coronary artery disease, ischemic stroke, type 2 diabetes, and chronic kidney disease.

16 June 2020 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
TETali Elfassy
Tali Elfassy
AHAdina Zeki Al Hazzouri
Adina Zeki Al Hazzouri
JCJianwen Cai
Jianwen Cai
PBPedro L. Baldoni
Pedro L. Baldoni
MLMaria M. Llabre
Maria M. Llabre
NSNeil Schneiderman
Neil Schneiderman
Background: Among US Hispanics/Latinos, the largest ethnic minority population in the United States, hypertension incidence has not been thoroughly reported. The goal of this study was to describe the incidence of hypertension among US Hispanic/Latino men and women of diverse Hispanic/Latino background. Methods and Results: We studied 6171 participants of the Hispanic Community Health Study/Study of Latinos, a diverse group of self‐identified Hispanics/Latinos from 4 US urban communities, aged 18 to 74 years, and free from hypertension in 2008 to 2011 and re‐examined in 2014 to 2017. Hypertension was defined as self‐reported use of anti‐hypertension medication, or measured systolic blood pressure ≥130 mm Hg, or diastolic blood pressure ≥80 mm Hg. Results were weighted given the complex survey design to reflect the target population. Among men, the 6‐year age‐adjusted probability of developing hypertension was 21.7% (95% CI , 19.5–24.1) and differed by Hispanic/Latino background. Specifically, the probability was significantly higher among men of Cuban (27.1%; 95% CI , 20.2–35.2) and Dominican (28.1%; 95% CI , 19.5–38.8) backgrounds compared with Mexican Americans (17.6%; 95% CI : 14.5–21.2). Among women, the 6‐year age‐adjusted probability of developing hypertension was 19.7% (95% CI , 18.1–21.5) and also differed by Hispanic/Latino background. Specifically, the probability was significantly higher among women of Cuban (22.6%; 95% CI , 18.3–27.5), Dominican (23.3%; 95% CI , 18.0–29.5), and Puerto Rican (28.2%; 95% CI , 22.7–34.4) backgrounds compared with Mexican Americans (16.0%; 95% CI , 13.9–18.4). Conclusions: Hypertension incidence varies by Hispanic/Latino background, with highest incidence among those of Caribbean background.

2 June 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
NKNuzulul Kurniansyah
Nuzulul Kurniansyah
MGMatthew O. Goodman
Matthew O. Goodman
AKAlyna T. Khan
Alyna T. Khan
JWJiongming Wang
Jiongming Wang
EFElena. V. Feofanova
Elena. V. Feofanova
TSTamar Sofer
Tamar Sofer
We assess performance and limitations of polygenic risk scores (PRSs) for multiple blood pressure (BP) phenotypes in diverse population groups. We compare “clumping-and-thresholding” (PRSice2) and LD-based (LDPred2) methods to construct PRSs from each of multiple GWAS, as well as multi-PRS approaches that sum PRSs with and without weights, including PRS-CSx. We use datasets from the MGB Biobank, TOPMed study, UK biobank, and from All of Us to train, assess, and validate PRSs in groups defined by self-reported race/ethnic background (Asian, Black, Hispanic/Latino, and White). For both SBP and DBP, the PRS-CSx based PRS, constructed as a weighted sum of PRSs developed from multiple independent GWAS, perform best across all race/ethnic backgrounds. Stratified analysis in All of Us shows that PRSs are better predictive of BP in females compared to males, individuals without obesity, and middle-aged (40-60 years) compared to older and younger individuals.

1 April 2019 in Stroke
Verified
Journal Article
Closed access
PDF file
TETali Elfassy
Tali Elfassy
LGLeslie Grasset
Leslie Grasset
MGM. Maria Glymour
M. Maria Glymour
SSSamuel Swift
Samuel Swift
LZLanyu Zhang
Lanyu Zhang
AHAdina Zeki Al Hazzouri
Adina Zeki Al Hazzouri
Background and Purpose—: It is unclear whether disparities in mortality among stroke survivors exist long term. Therefore, the purpose of the current study is to describe rates of longer term mortality among stroke survivors (ie, beyond 30 days) and to determine whether socioeconomic disparities exist. Methods—: This analysis included 1329 black and white participants, aged ≥45 years, enrolled between 2003 and 2007 in the REGARDS study (Reasons for Geographic and Racial Differences in Stroke) who suffered a first stroke and survived at least 30 days after the event. Long-term mortality among stroke survivors was defined in person-years as time from 30 days after a first stroke to date of death or censoring. Mortality rate ratios (MRRs) were used to compare rates of poststroke mortality by demographic and socioeconomic characteristics. Results—: Among adults who survived ≥30 days poststroke, the age-adjusted rate of mortality was 82.3 per 1000 person-years (95% CI, 75.4–89.2). Long-term mortality among stroke survivors was higher in older individuals (MRR for 75+ versus <65, 3.2; 95% CI, 2.6–4.1) and among men than women (MRR, 1.3; 95% CI, 1.1–1.6). It was also higher among those with less educational attainment (MRR for less than high-school versus college graduate, 1.5; 95% CI, 1.1–1.9), lower income (MRR for <$20k versus >50k, 1.4; 95% CI, 1.1–1.9), and lower neighborhood socioeconomic status (SES; MRR for low versus high neighborhood SES, 1.4; 95% CI, 1.1–1.7). There were no differences in age-adjusted rates of long-term poststroke mortality by race, rurality, or US region. Conclusions—: Rates of long-term mortality among stroke survivors were higher among individuals with lower SES and among those residing in neighborhoods of lower SES. These results emphasize the need for improvements in long-term care poststroke, especially among individuals of lower SES.

1 July 2023 in Hypertension
Verified
Journal Article
Closed access
TETali Elfassy
Tali Elfassy
CGCharles A. German
Charles A. German
PMPaul Muntner
Paul Muntner
ECEung Ho Choi
Eung Ho Choi
GCGabriel Contreras
Gabriel Contreras
EYEugene Yang
Eugene Yang
Background: Most research examining the association between blood pressure (BP) and cardiovascular disease (CVD) is sex-agnostic. Our goal was to assess sex-specific associations between BP and CVD mortality. Methods: We combined ten cycles of the National Health and Nutrition Examination Survey (1999–2018), N=53 289. Blood pressure was measured 3× and averaged. Data were linked to National Death Index data, and CVD mortality through December 31, 2019, was defined from International Classification of Diseases, Tenth Revision codes. We estimated sex-stratified, multivariable-adjusted incidence rate ratios (IRRs) for CVD mortality. Results: Over a median follow-up of 9.5 years, there were 2405 CVD deaths. Associations between categories of systolic blood pressure (SBP) and diastolic blood pressure (DBP) with CVD mortality differed by sex ( P <0.01). Among men, compared with SBP of 100 to <110 mm Hg, CVD mortality was 76% higher with SBP ≥160 mm Hg (IRR, 1.76 [95% CI, 1.27–2.44]). Among women, compared with SBP 100 to < 110 mm Hg, CVD mortality was 61% higher with SBP 130 to 139 mm Hg (IRR, 1.61 [95% CI, 1.02–2.55]), 75% higher with SBP 140 to 159 mm Hg (IRR, 1.75 [95% CI, 1.09–2.80]), and 113% higher with SBP≥160 mm Hg (IRR, 2.13 [95% CI, 1.35–3.36]). Compared with DBP 70 to <80 mm Hg, CVD mortality was higher with DBP <70 mm Hg and DBP≥80 mm Hg among men, and higher with DBP <50 mm Hg and DBP≥80 mm Hg among women. Conclusions: The association between BP and CVD mortality differed by sex, with increased CVD mortality risk present at lower levels of systolic blood pressure among women compared with men.

10 January 2018 in Obesity
Verified
Journal Article
Open access
PDF file
TETali Elfassy
Tali Elfassy
YMYasmin Mossavar‐Rahmani
Yasmin Mossavar‐Rahmani
LHLinda Van Horn
Linda Van Horn
MGMarc Gellman
Marc Gellman
DSDaniela Sotres‐Alvarez
Daniela Sotres‐Alvarez
AHAdina Zeki Al Hazzouri
Adina Zeki Al Hazzouri
Objective: The objective of this study was to evaluate cross‐sectional associations of sodium and potassium with BMI, waist circumference (WC), and body fat and to determine whether the nativity and/or duration of United States (US) residence modified these associations.Methods: Sodium and potassium were derived from 24‐hour diet recalls from 16,156 US participants of the 2008 to 2011 Hispanic Community Health Study/Study of Latinos (HCHS/SOL) and from 24‐hour urine in 447 HCHS/SOL participants. BMI, WC, and body fat were measured.Results: Dietary sodium that was 500 mg/d higher was cross‐sectionally associated with a 0.07‐kg/m2 higher BMI (P < 0.05) and a 0.18‐cm larger WC (P = 0.04). Dietary potassium that was 500 mg/d higher was only associated with lower BMI and smaller WC among those who were foreign‐born with 10 + years in the US (−0.13 kg/m2, P < 0.01 and −0.36 cm, P = 0.01, respectively) and among those who were US‐born (−0.62 kg/m2, P < 0.01 and −1.42 cm, P < 0.01, respectively). Urinary sodium that was 500 mg/d higher was associated with a 0.27‐kg/m2 higher BMI (P < 0.01) and 0.54 kg more body fat (P < 0.01).Conclusions: Sodium intake was associated with higher BMI, WC, and body fat. Potassium intake was associated with lower BMI and smaller WC among US‐born participants and participants with a longer duration of US residence.